| Diagnosis . | Total . | Newborns . | TGA . | TBA . |
|---|---|---|---|---|
| Patients (female) | 50 (7) | 44 (6) | 13 (0) | 37 (7) |
| Age (days), range | 7 (5–9), 2–1576 | 7 (5–11), 2–22 | 6 (5–9), 3–63 | 7 (6–11), 2–1576 |
| Weight (kg), range | 3.4 (2.9–3.8), 1.8–16 | 3.3 (2.9–3.7), 1.8–4.5 | 3.7 (3.1–3.8), 2.03–5.4 | 3.3 (2.9–3.8), 1.8–16 |
| VSD type | Perimembranous: 5 | Perimembranous: 7 | Subpulmonary: 32 | |
| None: 5 | None: 6 | Special: 5a | ||
| Subpulmonary: 30 | ||||
| Special: 4a | ||||
| AA obstruction | ||||
| Hypoplastic AA | 29 (58%) | 25 (56.8%) | 6 (46.2%) | 23 (62.2%) |
| Coarctation | 16 (32%) | 15 (34.1%) | 6 (46.2%) | 10 (27%) |
| Interrupted AA | 5 (10%) | 4 (9.1%) | 1 (7.7%) | 4 (10.8%) |
| Type A: 3 (6%) | Type A: 2 (4.5%) | Type B: 1 (7.7%) | Type A: 3 (8.1%) | |
| Type B: 2 (4%) | Type B: 2 (4.5%) | Type B: 1 (2.7%) | ||
| Coronary anatomy, Yacoub type | A: 25 (50%) | A: 23 (52.3%) | A: 9 (69.2%) | A: 16 (43.2%) |
| B: 5 (10%) | B: 4 (9.1%) | B: 2 (15.4%) | B: 3 (8.1%) | |
| C: 5 (10%) | C: 3 (6.8%) | C: 0 (0.0%) | C: 5 (13.5%) | |
| D: 7 (14%) | D: 6 (13.6%) | D: 0 (0.0%) | D: 7 (18.9%) | |
| E: 7 (14%) | E: 7 (15.9%) | E: 1 (7.7%) | E: 6 (16.2%) | |
| 1RLCx: 1 (2%) | 1RLCx: 1 (2.3%) | 1RLCx: 1 (7.7%) | ||
| Position of the aorta | ||||
| Side by side or slightly anterior (aorta right) | 23 (46%) | 21 (47.7%) | 0 (0%) | 23 (62.2%) |
| Slightly anterior (aorta left) | 1 (2%) | 0 (0%) | 0 (0%) | 1 (2.7%) |
| Completely or significantly anterior | 26 (52%) | 23 (52.3%) | 13 (100%) | 13 (35.1%) |
| Left superior vena cava | 3 (6%) | 2 (4.5%) | 0 (0%) | 3 (8.1%) |
| Bypass time (min) | 273 (248–313) | 273 (250–306) | 248 (235–265) | 282 (259–317) |
| ACCT (min) | 142 (126–158) | 142 (127–157) | 120 (103–131) | 147 (134–165) |
| Delayed chest closure | 13 (26.5%) | 12 (27.3%) | 1 (7.7%) | 12 (33.3%) |
| Diagnosis . | Total . | Newborns . | TGA . | TBA . |
|---|---|---|---|---|
| Patients (female) | 50 (7) | 44 (6) | 13 (0) | 37 (7) |
| Age (days), range | 7 (5–9), 2–1576 | 7 (5–11), 2–22 | 6 (5–9), 3–63 | 7 (6–11), 2–1576 |
| Weight (kg), range | 3.4 (2.9–3.8), 1.8–16 | 3.3 (2.9–3.7), 1.8–4.5 | 3.7 (3.1–3.8), 2.03–5.4 | 3.3 (2.9–3.8), 1.8–16 |
| VSD type | Perimembranous: 5 | Perimembranous: 7 | Subpulmonary: 32 | |
| None: 5 | None: 6 | Special: 5a | ||
| Subpulmonary: 30 | ||||
| Special: 4a | ||||
| AA obstruction | ||||
| Hypoplastic AA | 29 (58%) | 25 (56.8%) | 6 (46.2%) | 23 (62.2%) |
| Coarctation | 16 (32%) | 15 (34.1%) | 6 (46.2%) | 10 (27%) |
| Interrupted AA | 5 (10%) | 4 (9.1%) | 1 (7.7%) | 4 (10.8%) |
| Type A: 3 (6%) | Type A: 2 (4.5%) | Type B: 1 (7.7%) | Type A: 3 (8.1%) | |
| Type B: 2 (4%) | Type B: 2 (4.5%) | Type B: 1 (2.7%) | ||
| Coronary anatomy, Yacoub type | A: 25 (50%) | A: 23 (52.3%) | A: 9 (69.2%) | A: 16 (43.2%) |
| B: 5 (10%) | B: 4 (9.1%) | B: 2 (15.4%) | B: 3 (8.1%) | |
| C: 5 (10%) | C: 3 (6.8%) | C: 0 (0.0%) | C: 5 (13.5%) | |
| D: 7 (14%) | D: 6 (13.6%) | D: 0 (0.0%) | D: 7 (18.9%) | |
| E: 7 (14%) | E: 7 (15.9%) | E: 1 (7.7%) | E: 6 (16.2%) | |
| 1RLCx: 1 (2%) | 1RLCx: 1 (2.3%) | 1RLCx: 1 (7.7%) | ||
| Position of the aorta | ||||
| Side by side or slightly anterior (aorta right) | 23 (46%) | 21 (47.7%) | 0 (0%) | 23 (62.2%) |
| Slightly anterior (aorta left) | 1 (2%) | 0 (0%) | 0 (0%) | 1 (2.7%) |
| Completely or significantly anterior | 26 (52%) | 23 (52.3%) | 13 (100%) | 13 (35.1%) |
| Left superior vena cava | 3 (6%) | 2 (4.5%) | 0 (0%) | 3 (8.1%) |
| Bypass time (min) | 273 (248–313) | 273 (250–306) | 248 (235–265) | 282 (259–317) |
| ACCT (min) | 142 (126–158) | 142 (127–157) | 120 (103–131) | 147 (134–165) |
| Delayed chest closure | 13 (26.5%) | 12 (27.3%) | 1 (7.7%) | 12 (33.3%) |
Data are presented as the median (interquartile range) or numbers.
Multiple VSDs (n = 2), restrictive VSD (n = 2) and large VSD reaching into inlet septum (n = 1).
AA: aortic arch; ACCT: aortic cross-clamp time; TBA: Taussig–Bing anomaly; TGA: transposition of the great arteries; VSDs: ventricular septal defects.
| Diagnosis . | Total . | Newborns . | TGA . | TBA . |
|---|---|---|---|---|
| Patients (female) | 50 (7) | 44 (6) | 13 (0) | 37 (7) |
| Age (days), range | 7 (5–9), 2–1576 | 7 (5–11), 2–22 | 6 (5–9), 3–63 | 7 (6–11), 2–1576 |
| Weight (kg), range | 3.4 (2.9–3.8), 1.8–16 | 3.3 (2.9–3.7), 1.8–4.5 | 3.7 (3.1–3.8), 2.03–5.4 | 3.3 (2.9–3.8), 1.8–16 |
| VSD type | Perimembranous: 5 | Perimembranous: 7 | Subpulmonary: 32 | |
| None: 5 | None: 6 | Special: 5a | ||
| Subpulmonary: 30 | ||||
| Special: 4a | ||||
| AA obstruction | ||||
| Hypoplastic AA | 29 (58%) | 25 (56.8%) | 6 (46.2%) | 23 (62.2%) |
| Coarctation | 16 (32%) | 15 (34.1%) | 6 (46.2%) | 10 (27%) |
| Interrupted AA | 5 (10%) | 4 (9.1%) | 1 (7.7%) | 4 (10.8%) |
| Type A: 3 (6%) | Type A: 2 (4.5%) | Type B: 1 (7.7%) | Type A: 3 (8.1%) | |
| Type B: 2 (4%) | Type B: 2 (4.5%) | Type B: 1 (2.7%) | ||
| Coronary anatomy, Yacoub type | A: 25 (50%) | A: 23 (52.3%) | A: 9 (69.2%) | A: 16 (43.2%) |
| B: 5 (10%) | B: 4 (9.1%) | B: 2 (15.4%) | B: 3 (8.1%) | |
| C: 5 (10%) | C: 3 (6.8%) | C: 0 (0.0%) | C: 5 (13.5%) | |
| D: 7 (14%) | D: 6 (13.6%) | D: 0 (0.0%) | D: 7 (18.9%) | |
| E: 7 (14%) | E: 7 (15.9%) | E: 1 (7.7%) | E: 6 (16.2%) | |
| 1RLCx: 1 (2%) | 1RLCx: 1 (2.3%) | 1RLCx: 1 (7.7%) | ||
| Position of the aorta | ||||
| Side by side or slightly anterior (aorta right) | 23 (46%) | 21 (47.7%) | 0 (0%) | 23 (62.2%) |
| Slightly anterior (aorta left) | 1 (2%) | 0 (0%) | 0 (0%) | 1 (2.7%) |
| Completely or significantly anterior | 26 (52%) | 23 (52.3%) | 13 (100%) | 13 (35.1%) |
| Left superior vena cava | 3 (6%) | 2 (4.5%) | 0 (0%) | 3 (8.1%) |
| Bypass time (min) | 273 (248–313) | 273 (250–306) | 248 (235–265) | 282 (259–317) |
| ACCT (min) | 142 (126–158) | 142 (127–157) | 120 (103–131) | 147 (134–165) |
| Delayed chest closure | 13 (26.5%) | 12 (27.3%) | 1 (7.7%) | 12 (33.3%) |
| Diagnosis . | Total . | Newborns . | TGA . | TBA . |
|---|---|---|---|---|
| Patients (female) | 50 (7) | 44 (6) | 13 (0) | 37 (7) |
| Age (days), range | 7 (5–9), 2–1576 | 7 (5–11), 2–22 | 6 (5–9), 3–63 | 7 (6–11), 2–1576 |
| Weight (kg), range | 3.4 (2.9–3.8), 1.8–16 | 3.3 (2.9–3.7), 1.8–4.5 | 3.7 (3.1–3.8), 2.03–5.4 | 3.3 (2.9–3.8), 1.8–16 |
| VSD type | Perimembranous: 5 | Perimembranous: 7 | Subpulmonary: 32 | |
| None: 5 | None: 6 | Special: 5a | ||
| Subpulmonary: 30 | ||||
| Special: 4a | ||||
| AA obstruction | ||||
| Hypoplastic AA | 29 (58%) | 25 (56.8%) | 6 (46.2%) | 23 (62.2%) |
| Coarctation | 16 (32%) | 15 (34.1%) | 6 (46.2%) | 10 (27%) |
| Interrupted AA | 5 (10%) | 4 (9.1%) | 1 (7.7%) | 4 (10.8%) |
| Type A: 3 (6%) | Type A: 2 (4.5%) | Type B: 1 (7.7%) | Type A: 3 (8.1%) | |
| Type B: 2 (4%) | Type B: 2 (4.5%) | Type B: 1 (2.7%) | ||
| Coronary anatomy, Yacoub type | A: 25 (50%) | A: 23 (52.3%) | A: 9 (69.2%) | A: 16 (43.2%) |
| B: 5 (10%) | B: 4 (9.1%) | B: 2 (15.4%) | B: 3 (8.1%) | |
| C: 5 (10%) | C: 3 (6.8%) | C: 0 (0.0%) | C: 5 (13.5%) | |
| D: 7 (14%) | D: 6 (13.6%) | D: 0 (0.0%) | D: 7 (18.9%) | |
| E: 7 (14%) | E: 7 (15.9%) | E: 1 (7.7%) | E: 6 (16.2%) | |
| 1RLCx: 1 (2%) | 1RLCx: 1 (2.3%) | 1RLCx: 1 (7.7%) | ||
| Position of the aorta | ||||
| Side by side or slightly anterior (aorta right) | 23 (46%) | 21 (47.7%) | 0 (0%) | 23 (62.2%) |
| Slightly anterior (aorta left) | 1 (2%) | 0 (0%) | 0 (0%) | 1 (2.7%) |
| Completely or significantly anterior | 26 (52%) | 23 (52.3%) | 13 (100%) | 13 (35.1%) |
| Left superior vena cava | 3 (6%) | 2 (4.5%) | 0 (0%) | 3 (8.1%) |
| Bypass time (min) | 273 (248–313) | 273 (250–306) | 248 (235–265) | 282 (259–317) |
| ACCT (min) | 142 (126–158) | 142 (127–157) | 120 (103–131) | 147 (134–165) |
| Delayed chest closure | 13 (26.5%) | 12 (27.3%) | 1 (7.7%) | 12 (33.3%) |
Data are presented as the median (interquartile range) or numbers.
Multiple VSDs (n = 2), restrictive VSD (n = 2) and large VSD reaching into inlet septum (n = 1).
AA: aortic arch; ACCT: aortic cross-clamp time; TBA: Taussig–Bing anomaly; TGA: transposition of the great arteries; VSDs: ventricular septal defects.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
